Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
26 Jun 2026
FGFR2 Amplified Gastric Cancer Responds to Infigratinib
Phase 2 data show infigratinib achieved a 23.8% objective response rate in FGFR2 amplified gastric cancer, supporting further evaluation of targeted treatment strategies.
26 Jun 2026
MVX Score Predicts Mortality Risk in MASLD
The MVX score may help identify patients with MASLD who are at greatest risk of death and liver-related complications.
26 Jun 2026
AI Shows Promise in Radiotherapy-Associated Cardiovascular Toxicity
AI shows promise for radiotherapy-associated cardiovascular toxicity, a major concern for cancer survivors, a new systematic review has found.
MHRA issues warning against promoting unlicensed drugs
A joint warning has been issued against promoting newly licensed prescription-only and unlicensed medicines for weight management.
UNICEF and Gavi call to accelerate Bundibugyo vaccine access
UNICEF and Gavi have made a call to manufacturers to accelerate access to a Bundibugyo vaccine, amid the ongoing Ebola outbreak in the Democratic Republic of the Congo and Uganda.
25 Jun 2026
FDA Clears First Over-the-Counter CGM for Children
The US FDA has cleared for marketing the first over-the-counter continuous glucose monitor for children.
25 Jun 2026
Gut Interoception Predicts Relapse in Anorexia Nervosa
New research links disrupted gut interoception to relapse risk in weight-restored anorexia nervosa, suggesting ingestible probes could become biomarkers.
25 Jun 2026
Psychosocial Screening Tools Could Improve Cancer Care
Psychosocial screening tools can rapidly detect distress, anxiety, depression, and death anxiety in cancer care.
25 Jun 2026
Traumatic Encephalopathy Syndrome Features Common After TBI
Traumatic encephalopathy syndrome features were common after traumatic brain injury, even without repetitive head impacts.
25 Jun 2026
Social Distancing Linked to Lasting Health Burden
Physical distancing was tied to poorer quality of life in immunocompromised adults years after COVID-19 emerged.
←
1
2
3
4
5
…
1,649
1,650
1,651
→
We’ve noticed you’re accessing
from
North/South America.
View
View